methylprednisolone has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shiba, DA; Weinkam, RJ | 1 |
| Hayat, M; Mathé, G; Schneider, M; Schwarzenberg, L | 1 |
2 other study(ies) available for methylprednisolone and Leukemia L 1210
| Article | Year |
|---|---|
The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarba
Topics: Animals; Drug Interactions; Leukemia L1210; Male; Methylprednisolone; Mice; Mice, Inbred Strains; Phenobarbital; Phenytoin; Procarbazine | 1983 |
[Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
Topics: Animals; Cyclophosphamide; Daunorubicin; Leucovorin; Leukemia L1210; Life Expectancy; Mercaptopurine; Methotrexate; Methylprednisolone; Mice; Statistics as Topic; Vinblastine; Vincristine | 1968 |